Scholarly Index
Bradley C. Leibovich
Mayo Clinic in Arizona; 35,033 total citations; 715 total publications; best world rank #15
Mayo Clinic in Arizona
35,033Total citations
715Total publications
99H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Renal cell carcinoma treatment | Lifetime | 15 | US 12 | 99.84 |
| Renal and related cancers | Lifetime | 21 | US 18 | 99.76 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 35 | US 24 | 99.73 |
| Multiple and Secondary Primary Cancers | Lifetime | 25 | US 11 | 99.56 |
| Cancer Genomics and Diagnostics | Lifetime | 455 | US 262 | 99.14 |
| Renal and Vascular Pathologies | Lifetime | 276 | US 165 | 98.15 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 839 | US 415 | 98.26 |
| MRI in cancer diagnosis | Lifetime | 396 | US 180 | 97.90 |
| Prostate Cancer Treatment and Research | Lifetime | 658 | US 351 | 98.19 |
| Cardiac tumors and thrombi | Lifetime | 303 | US 151 | 97.20 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 609 | US 297 | 98.11 |
| Urinary and Genital Oncology Studies | Lifetime | 807 | US 344 | 95.41 |
| Tuberous Sclerosis Complex Research | Lifetime | 166 | US 98 | 93.04 |
| Urologic and reproductive health conditions | Lifetime | 890 | US 425 | 94.92 |
| Renal cell carcinoma treatment | 2021-2025 | 240 | US 94 | 96.09 |
| Renal and related cancers | 2021-2025 | 336 | US 139 | 90.63 |
| Tuberous Sclerosis Complex Research | 2021-2025 | 272 | US 106 | 62.07 |